Susan K. Whoriskey
Director/Board Member at Ratio Therapeutics, Inc.
Susan K. Whoriskey active positions
Companies | Position | Start | End |
---|---|---|---|
Ratio Therapeutics, Inc.
Ratio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ratio Therapeutics, Inc. is a pharmaceutical company based in the United States. The company is based in Boston, MA. The company's mission is to accelerate the development of next-generation precision radiopharmaceuticals for solid tumors and transform oncology treatment paradigms. The company's fully integrated proprietary R&D platforms, Trillium™ and Macropa™, enable the imaging, discovery, and advancement of novel radiopharmaceuticals that have first/best-in-class delivery, safety, and efficacy properties. Founded by John Babich, Ph.D., and Jack Hoppin, Ph.D., the company employs a growing team of radiopharmaceuticals discovery and development experts with backgrounds in the life science industry. The CEO of the company is Jack William Hoppin. | Director/Board Member | 31/01/2023 | - |
Career history of Susan K. Whoriskey
Former positions of Susan K. Whoriskey
Companies | Position | Start | End |
---|---|---|---|
MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Statistics
International
United States | 3 |
Operational
Corporate Officer/Principal | 1 |
Director/Board Member | 1 |
Sectoral
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Momenta Pharmaceuticals, Inc.
Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Ratio Therapeutics, Inc.
Ratio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ratio Therapeutics, Inc. is a pharmaceutical company based in the United States. The company is based in Boston, MA. The company's mission is to accelerate the development of next-generation precision radiopharmaceuticals for solid tumors and transform oncology treatment paradigms. The company's fully integrated proprietary R&D platforms, Trillium™ and Macropa™, enable the imaging, discovery, and advancement of novel radiopharmaceuticals that have first/best-in-class delivery, safety, and efficacy properties. Founded by John Babich, Ph.D., and Jack Hoppin, Ph.D., the company employs a growing team of radiopharmaceuticals discovery and development experts with backgrounds in the life science industry. The CEO of the company is Jack William Hoppin. | Health Technology |
- Stock Market
- Insiders
- Susan K. Whoriskey
- Experience